Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-05-29
2007-05-29
Schultz, James (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C514S04400A, C435S006120, C435S320100
Reexamination Certificate
active
09214386
ABSTRACT:
The invention relates to oligonucleotides from the untranslated regions of housekeeping genes, and methods and compositions for modulating cell growth using same. Specifically it relates to the use of the untranslated regions (UTR) from housekeeping genes specifically the R1 and R2 components of ribonucleotide reductase UTR, for inhibiting tumor cell growth.
REFERENCES:
patent: 4358535 (1982-11-01), Falkow et al.
patent: 4736866 (1988-04-01), Leder et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 5175383 (1992-12-01), Leder et al.
patent: 5175384 (1992-12-01), Krimpenfort et al.
patent: 5175385 (1992-12-01), Wagner et al.
patent: 5221778 (1993-06-01), Byrne et al.
patent: 5225347 (1993-07-01), Goldberg et al.
patent: 5288846 (1994-02-01), Quertermous et al.
patent: 5298422 (1994-03-01), Schwartz et al.
patent: 5347075 (1994-09-01), Sorge
patent: 5360735 (1994-11-01), Weinshank et al.
patent: 5387742 (1995-02-01), Cordell
patent: 5464764 (1995-11-01), Capecchi et al.
patent: 5487992 (1996-01-01), Capecchi et al.
patent: 5601818 (1997-02-01), Freeman et al.
patent: 5614396 (1997-03-01), Bradley et al.
patent: 5998383 (1999-12-01), Wright et al.
patent: 6342483 (2002-01-01), Holt et al.
patent: 0 383 190 (1990-08-01), None
patent: 0 726 277 (1996-08-01), None
patent: WO 93/14200 (1993-07-01), None
patent: WO 93/17125 (1993-09-01), None
patent: WO 94/06908 (1994-03-01), None
patent: WO 94/28123 (1994-05-01), None
patent: 94/21661 (1994-09-01), None
patent: WO 94/23049 (1994-10-01), None
patent: 95/02069 (1995-01-01), None
patent: 98/00532 (1998-01-01), None
Anderson, Nature 392/Supp. p. 25-30, Apr. 1998.
Branch, TIBS 23 p. 45-50, Feb. 1998.
Flanagan et al., Nature Biotech. 17:48-52, Jan. 1999.
Crystal, Science vol. 270, p. 404-410, Oct. 1995.
Pavloff et al, DNA Sequence, vol. 2, pp. 227-234, 1992.
Amara et al, NAR vol. 23, No. 9, p. 1461-1467, 1995.
Chandra Sekharappa et al. vol. 12, No. 1, p. 173-180, Jan. 1986.
Chen et al., EMBO vol. 12 No. 10. pp. 3977-3986, 1993.
Voss et al., J. Biol. Chem, vol. 266 No. 21, pp. 13706-13711, 1991.
Tsa et al., J. Biol. Chem., vol. 266 No. 34, pp. 23053-23059, 1991.
Braidotti et al., J. Biol. Chem., vol. 268 No. 2, pp. 1109-1117, 1993.
Hilfiker et al., J. Biol. Chem., vol. 268 No. 26, pp. 19717-19725, 1993.
Michael J. McCluskie et al., Route and Method of Delivery of DNA Vaccine Influence Immune Responses In Mice and Non-Human Primates; Molecular Medicine, vol. 5, No. 5 May 1999 pp. 287-300.
J. Gomez-Navarro et al., Gene Therapy for Cancer; European Journal of Cancer, vol. 35, No. 6 pp. 867-885, 1999.
Agrawal et al., Molecular Medinine Today, 2000, vol. 6, p. 72-81.
Opalinska et al. Nature Reviews Drug Discovery, 2002, vol. 1, p. 503-514.
Jen et al. Stem Cells 2000, vol. 18, p. 307-319.
Agrawal, S., et al. “Antisense therapeutics”Current Opinion in Chemical Biology, 2:519-528, (1998).
Schabet, M., et al., “Animal models of leptomeningeal metastasis”Journal of Neuro-Oncology, 38:199-205, (1998).
Thelander, L., et al., “Isolation and Characterization of Expressible CDNA Clones Encoding the M1 and M2 Subunits of Mouse Ribonucleotide Reductase”Molecular and Cellular Biology, vol. 6, No. 10, pp. 3433-3442, (Oct. 1986).
Takeda, E., et al., “Role of Ribonucleotide Reductase In Expression Of The Neoplastic Program”Life Sciences, vol. 28, pp. 1007-1014 (1981).
Kijima, H., et al., “Therapeutic Applications of Ribozymes”Pharmac. Ther., vol. 68, No. 2, pp. 247-267, (1995) XP 000612090.
Amara, F.M., et al, Altered Regulation of Message Stability and Tumor Promoter-responsivecis-transInteractions of Ribonucleotide Reductase R1 and R2 Messenger RNAs in Hydroxyurea-resistant Cells, Cancer Research, 55:4503-4506, 1995.
Amara, F.M., et al., A novel transforming growth factor-beta responsive cytoplasmic trans-acting factor binds selectively to the 3'-untranslated region of mammalian ribonucleotide reductase R2 mRNA: role in message stability, Nucleic Acids Research, 21:4803-4809, 1993.
Altschul, S.F., et al., Basic Local Alignment Search Tool, 403-410, 1990.
Chen, F.Y., et al., Mammalian ribonucleotide reductase R1 mRNA Stability under normal and phorbol ester stimulating conditions: involvement of acis-transinteraction at the 3' untranslated region, The EMBO Journal, 12(10):3977-3986, 1993.
Cregg, J.M., et al., Recent Advances in the Expression of Foreign Genes inPichia pastoris, Bio/Technology, 11:905-910, 1993.
Fan, H., et al., Suppression of Malignancy by the 3' Untranslated Regions of Ribonucleotide Reductase R1 and R2 Messenger RNAs, Cancer Research, 56:4366-4369, 1996.
Greene, L.A., et al., Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor, Proc. Natl. Acad. Sci. USA, 73(7):2424-2428, 1976.
Gubler U. and Hoffman, B.J., A simple and very efficient method for generating cDNA libraries, Gene, 45:263-269, 1983.
Parker, N.J., et al., Human M1 subunit of ribonucleotide reductase: cDNA sequence and expression in stimulated lymphocytes, Nucleic Acids Research, 19(13):3741, 1991.
Pavloff, N., et al., Sequence analysis of the large and small subunits of human ribonucleotide reductase, DNA Sequence, 2:227-234, 1992.
EMBL/GenBank/DDBJ Databases, Accession number No. aa452273, Unpublished, created Jun. 11, 1997, Hillier, et al., “WachU-Merck Est Project 1997”, XP002048834.
EMBL/GenBank/DDBJ Databases, Accession number No. g07100, Unpublished, created Jun. 15, 1995, Hudson, et al., “The Whitehead Institute/MIT Center for Genome Research; Physically mapped ESTs”, XP002048239.
Agrawal et al., 1991. Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci. USA 88:7595-7599.
Agrawal, 1996. Antisense oligonucleotides: towards clinical trials, TIBTECH, 14:376.
Akhter et al, 1991. Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes). Nuc. Res. 19:5551-5559.
Amara et al., 1994. Phorbol ester modulation of a novel cytoplasmic protein binding activity at the 3'-untranslated region of mammalian ribonucleotide reductase R2 mRNA and role in message stability. J. Biol. Chem. 269:6709-7071.
Amara et al., 1995B. Defining a novelciselement in the 3'-untranslated region of mammalian ribonucleotide reductase component R2 mRNA: Role in transforming growth factor-b1induced mRNA stabilization. Nucleic Acids Res. 23:1461-1467.
Amara et al. 1996. Defining a novelcis-element in the 3'-untranslated region of mammalian ribonucleotide reductase component R2 mRNA:cis-transinteractions and message stability. J. Biol. Chem. 271:20126-20131.
Ashihara and Baserga, 1979. Cell Synchronization. Methods Enzymol. 58:248-262.
Blaesse, 1997. Gene Therapy for Cancer. Scientific American 276(6):111-115.
Björklund et al., 1993. Structure and promoter characterization of the gene encoding the large subunit (R1 Protein) of mouse ribonucleotide reductase. Proc. Natl. Acad. Sci. USA 90:11322-11326.
Burke and Olson, “Preparation of Clone Libraries in Yeast Artificial-Chromosome Vectors” inMethods in Enzymology, vol. 194, “Guide to Yeast Genetics and Molecular Biology”, eds. C. Guthrie and G. Fink, Academic Press, Inc., Chap. 17, pp. 251-270 (1991).
Caceres and Kosik, 1990. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons. Nature, 343:461.
Capecchi, “Altering the genome by homologous recombination”Science244:1288-1292 (1989).
Caras, 1985. Cloned Mouse Ribonucleotide Reductase Subunit M1 cDNA Reveals Amino Acids Sequence Homology withEscherichia coliand Herpesvirus Ribonucleotide Reductases. Biol Chem. 260:7015-7022.
Chan et al., 1993. Phosophorylation of ribonucleotide reductase R2 protein:in vivoandin vitroevidence of a role for pd4cdc2and CDK2 protein kinases. Biochemistry 32:12835-12840.
Chen et al., 1993. Mammalian ribonucleotide reductase R1 mRNA stability under normal and phorbol ester stimulating conditions: involvement ofcis-transinteraction
Wright Jim A.
Young Aiping H.
Genesense Technologies Inc.
Heiman Lee C.
Nath Gary M.
Schultz James
The Nath Law Group
LandOfFree
Oligonucleotides from the untranslated regions of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides from the untranslated regions of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides from the untranslated regions of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3825353